HighTower Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
HighTower Advisors's ACLS Position: Q3 2026 in Review
HighTower Advisors reduced its Axcelis (ACLS) stake by 32% in Q3 2026, selling an estimated $252K and leaving 4,141 shares worth $543K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.
HighTower Advisors first reported a position in ACLS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.16M in Q2 2026. 394 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.
- HighTower Advisors held 4,141 shares of Axcelis worth $543K as of Q3 2026.
- HighTower Advisors sold 1,966 Axcelis shares in Q3 2026, an estimated $252K.
- Axcelis made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2672 holding.
- HighTower Advisors first reported a position in Axcelis in Q4 2022 and has held it in 14 quarters since.
- HighTower Advisors's Axcelis position peaked at $1.16M in Q2 2026.
- 394 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.